Markets

Aroa Biosurgery in trading halt for capital raise

Rebecca Stevenson
Tue, 27 Jul 2021

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
Tue, 27 Jul 2021
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Infrastructure
Analysts question Infratil's CDC, Vodafone mobile towers valuations
Jenny Ruth | Thu, 19 May 2022

Infratil's gearing is just 9.4% and it has about $1.67b of cash and bank facilities available.

Sport
The story behind NZ’s first big sporting NFT
Trevor McKewen | Thu, 19 May 2022

Some big sporting names have a big idea for the next big thing.

Primary Sector
Sanford's revenues lift but domestic challenges remain
Rebecca Howard | Thu, 19 May 2022

The board opted to not pay an interim dividend given the “early stage” of Sanford’s recovery.

Partner content
What’s driving the ram raids, and what shop owners can do

Scott La Franchie explains the motivations behind the spate of burglaries.

Partner content
Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.